Healthy Biotech
Latest round
- Series A
Last raised
- Aug 2024
Total raised
- Undisclosed
Investors
- 1
About Healthy Biotech
Founded in 2019 and based in Wuhan, China, Healthy Biotech is a biotech company that focuses on developing individualised molecular diagnostic reagents for blood diseases. The company is affiliated with ComSun Global. It has 40,000 square metres of laboratory and 3,300 square metres of GMP plant. The company's main products include PCR products, Sanger products and NGS products. PCR products include HemaFus BCR-ABL1 (P210 type) fusion gene high sensitivity detection kit and HemaMut human JAK2 gene V617F mutation detection kit. The company also provides auxiliary reagents and laboratory consumables. The company's products are used in diseases such as leukaemia, malignant lymphoma and multiple myeloma. The company's revenue is generated by providing individualised molecular diagnostic reagents for blood disorders.
Who invested in Healthy Biotech
1 investor across 1 round
See all investors in Healthy Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 29, 2024
Amount
Undisclosed
Investors
Questions about Healthy Biotech
Who invested in Healthy Biotech?
Healthy Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Healthy Biotech raised?
Healthy Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Healthy Biotech last raise money?
Healthy Biotech's most recent round on record is a Series A, in Aug 2024.
What does Healthy Biotech do?
Founded in 2019 and based in Wuhan, China, Healthy Biotech is a biotech company that focuses on developing individualised molecular diagnostic reagents for blood diseases.
Where is Healthy Biotech headquartered?
Healthy Biotech is headquartered in Wuhan, China.
Which VCs invest in companies like Healthy Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Healthy Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Healthy Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.